1[1] Barlett RR,Anagnostopulos H,Zielinski T,et al.Effects of leflun o mide on immune responses and models of inflammation.Springer Semin Immunopathal, 1993,14∶381-394.
2[2] Weaver A, Caldwell J, Olsen N et al. Treatment of active rheumat oid arthritis with leflunomide compared to placebo or methotrexate. ACR Concurre nt Session，1998, Abstract∶593.
3[3] Finnegan A,Siemasko K F,Williams J W，et al.Leflunomide inhibits immunog lobin prodution by two separate mechanism.ACR Poster Session,1997,40.
4[4] Barlett R.R，et al. Leflunomide, an imunorestoring drug for the therapy autoimmune disorders, especially rheumatoid. Current Opinion in Rheumatoid， 199 7，9∶410.
5[5] Prakash M, Jarvis B. Leflunomide, a review of its use in active rheumat oid arthritis.1999,58(6)∶1137-1164.
6[6] Weinblatt ME, Kremer JM, Coblyn JS，et al. Leflunomide plus methotrexate in refractory rheumatoid arthritis: A pilot study. ACR Poster Session，1997,Abs tract∶974.
7Bartlett RR,Brendel S,Zielinshi T,et al.Leflunomide,an immunorestoring drug for the therapy of autoimmune disorders,especially rheumatoid arthritis.Transplant Proc,1996,28:3074-3078.
8Breed FC,Dayer JM.Leflunomide:mode of action in treatment of rheumatoid arthritis.Ann Rheum Dis,2000,59:841-849.
9Maarten C,Kraan N,Richard J,et al.Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis.Arthritis Rheum,2000,43:1820-1830.
10Punchard NA,Boswell DJ,Greenfield SM,et al.The effects of sulphasalazine and metabolite on prostaglandin production by human mononuclear cells.Biochem Pharmacol,1992,43:2369-2376.
